Overview

Ketoprofen in Transfersome Compared to Oral Celecoxib and Placebo for Pain Associated With Osteoarthritis of the Knee

Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the safety and effectiveness of 110 mg ketoprofen in Transfersome applied to the skin twice daily as compared to placebo and oral celecoxib 200 mg per day for the relief of signs and symptoms of osteoarthritis of the knee for a period of six weeks.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
IDEA AG
Treatments:
Celecoxib
Ketoprofen
Criteria
Inclusion Criteria:

- Osteoarthritis of the knee for a minimum of six months

- Patient´s rating of pain in the index knee while not taking oral NSAIDs of at least 3
using a 5-point Likert scale

- Presenting two out of the three following criteria - Morning stiffness of less than 30
minutes duration, Crepitus on motion, Age >= 40 years

- Patients must have used oral NSAIDs at least 3 days per week for the 3 months prior to
screening or the patient was taking an NSAID on a regular basis (>25 out of 30 days)
at a therapeutic level for at least 30 days prior to screening

- Each of the following three criteria (the osteoarthritis flare criteria) must be met -
Index knee pain assessment at walking at least 40 mm on VAS at baseline, Increase of
index knee pain at walking by at least 15 mm on VAS at baseline compared to screening,
Physician´s global assessment of osteoarthritis 3-5 and at least 1 grade increase from
screening

Exclusion Criteria:

- Grade 1 or Grade 4 severity of the index knee based on Kellgren and Lawrence
radiographic criteria

- Intraarticular injections or arthroscopy of the index knee within 3 months prior to
screening

- Signs of any clinically important inflammation of the index knee including redness,
warmth and or a large bulging effusion with the loss of normal contour

- Crystalline-induced synovitis in the index knee

- History, physical examination or radiographic suggestive of acute inflammatory
arthritis, rheumatoid arthritis, psoriatic arthritis, septic arthritis, gout,
pseudogout, fibromyalgia, lupus erythematosus, or other types of inflammatory
arthritis of the index knee